Blog
Insights from the Invert team.
Perspectives on bioprocess data, AI in biomanufacturing, and building the intelligence layer for biopharma teams.
.png&w=3840&q=75)
Bioraptor vs. Invert vs. Genedata: Best Bioprocess AI Platform for Scale-Up & Pharma Manufacturing
Compare Bioraptor, Invert, and Genedata to see which bioprocess AI platform delivers the fastest scale-up, real-time insights, and AI-ready data for pharma and bioprocessing teams. Understand why experts choose Invert for USP, DSP, and manufacturing.
Read article
How to Integrate Bioprocess Data Across Sites, Systems, and CDMOs | Invert Bioprocess AI
Learn how to integrate bioprocess data across instruments, LIMS, sites, and CDMOs without manual work or IT burden. See how modern bioprocess teams accelerate scale-up with automation, harmonization, and built-in intelligence.
Read articleThe Bioprocess Scale-Up Playbook: From Fragmented Data to Confident Decisions
Learn how leading pharma, biologics, and vaccine teams close the scale-up gap with unified data, real-time visibility, and a built-in bioprocess intelligence layer. See how Invert transforms fragmented bioprocess data into faster, more confident decisions across development and manufacturing.
Read article
AI in Bioprocess Quality Control: Moving from Compliance to Confidence
Learn how AI powered bioprocess quality control software helps pharma and cell therapy manufacturers improve consistency, strengthen GxP compliance, and shift from reactive oversight to confident, real time decision making.
Read article
Best Practices for Bioprocess Data Integration
Learn the key best practices for integrating bioprocess data across development, scale up, CDMOs, and manufacturing. Discover how harmonized, contextualized, AI ready data accelerates insight and reduces risk.
Read article
How to Scale Up Bioprocess Manufacturing Without the Data Headaches
Learn how bioprocess teams are scaling manufacturing faster with AI-powered intelligence platforms that unify data, simplify tech transfer, and reduce risk in cell therapy and pharmaceutical production.
Read article
Connecting Shake Flask to Final Product with Lineage Views in Invert
Invert’s lineage view connects products across every unit operation and material transfer throughout the entire process. It acts as a family tree for your product, tracing its origins back through purification, fermentation, and inoculation. Instead of manually tracking down the source of each data point, lineages automatically show material streams as they pass through each step.
Read article
Engineer Blog Series: Invert Assist with Simon Sotak Gregor
Invert recently launched Invert Assist, our AI interface for bioprocess data analysis. We speak to senior software engineer Simon Sotak Gregor about Invert Assist to learn more about how it was built, what problems it solves, and how he hopes it’ll change the way bioprocess is done.
Read article
Engineer Blog Series: Integrations with Julia Miller
Senior software engineer Julia Miller speaks to us about Invert's integrations — how they're implemented, what makes them special, and what goes into making them work for bioprocess.
Read article
Invert Launches Alerts: Turning Real Time Data Into Immediate Action
Invert Alerts transform real time bioprocess data into immediate, actionable notifications so scientists can act in the moment, protect their runs, and focus on advancing processes instead of manually monitoring them
Read article
Meet Emily Nault, Invert’s New SVP of Commercial
Invert is excited to announce that Emily Nault has joined the company as our Senior Vice President of Commercial.
Read article
On-Demand Webinar: The Future of Data in Bioprocessing
Discover how bioprocessing data is evolving from spreadsheets to AI-driven insights. Watch the on-demand webinar to future-proof your digital strategy.
Read article
Top AI Tools Powering the Future of Biomanufacturing (2025 Edition)
Explore the leading AI platforms transforming biomanufacturing in 2025. Learn what sets the best bioprocess AI software apart and how Invert is redefining real-time manufacturing intelligence.
Read article
What Is Bioprocess AI? How Artificial Intelligence Is Transforming Manufacturing Intelligence
Learn how Bioprocess AI software unifies data, accelerates decision-making, and drives faster scale-up in biomanufacturing. Discover why the next wave of manufacturing intelligence starts with live, trusted data.
Read article
Why Bioprocess Data Fragmentation Is Slowing Down the Industry
Learn how fragmented bioprocess data creates risk, waste, and delays, and how an AI-ready data foundation helps unify insights, accelerate scale-up, and improve manufacturing outcomes.
Read article
Engineer Blog Series: Security & Compliance with Tiffany Huang
Welcome to Invert's Engineering Blog Series, a behind-the-scenes look into the product and how it's built. For our third post, senior software engineer Tiffany Huang speaks about how trust and security is a foundational principle at Invert, and how we ensure that data is kept secure, private, and compliant with industry regulations.
Read article
Analyzing Real-Time Time Series Data in Bioprocess with Invert
In modern biomanufacturing, success hinges on the ability to make informed decisions fast. The ability to analyze data directly impacts productivity, product quality, and ultimately, time to market, whether you're optimizing a fed-batch fermentation, troubleshooting a chromatography run, or validating a filtration process. However, its massive volume, high dimensionality, and low latency of time series data in bioprocess means that most software are not built to effectively capture, let alone analyze it.
Read article
AI That Bioprocess Teams Can Trust: Highlights from BioTalk Berlin
Recorded live at BioTalk Berlin on September 18, 2025 — featuring Michael McCutchen, Senior Product Manager at Invert. Scroll to the end to watch the full talk.
Read article
Introducing Invert Assist — Explainable AI for Bioprocess Quality Control, Monitoring, and Optimization
Biopharma teams don’t fail at AI because models are weak. They stall because data is fragmented. In our new webinar, we introduced Invert Assist—the AI layer purpose-built for bioprocessing—and showed how pairing explainable AI with a trusted, harmonized data foundation accelerates scale-up, improves bioprocess quality control, and cuts wasted runs.
Read article
The Best Real-Time Bioprocess Monitoring Platform for Biomanufacturing
See why Invert is the best real-time bioprocess monitoring platform for pharmaceutical manufacturing and scale-up. Live data, AI insights, compliance-ready.
Read article
7 Best AI Bioprocess Optimization Platforms for Pharmaceutical Manufacturing in 2025
The bioprocess optimization market is growing from $24.3B in 2024 to $39.6B by 2029, fueled by the shift to AI-driven digital biomanufacturing. These AI bioprocess platforms are leading the charge.
Read article
Best Bioprocess Data Integration Platforms for Pharmaceutical Manufacturing Teams in 2025
Pharmaceutical manufacturers face critical data integration challenges as bioprocess operations generate unprecedented volumes of fragmented information. Learn more about which leading platforms are also offering AI.
Read article
Invert Launches Invert Assist
Today, Invert launches Invert Assist, the first AI-powered analysis interface built for bioprocess. Using a simple chat interface, Invert Assist enables users to perform complex analysis that typically takes an expert team hours to code manually. With the freedom and flexibility of natural language, bioprocess scientists can turn days or even weeks of troubleshooting and optimization into a 5-minute conversation with their data.
Read article
How Invert uses batch context to make your data valuable—instantly
Bioprocess teams can spend dozens of hours every week exporting data and manually cutting it up to assign it to the batches they care about. We’ve built a way for users to easily add batch context, whether it’s just labeling data after a run, or pre-programming an integration to inject that context on the fly.We’ve built a way for users to easily add batch context, whether it’s labeling data after a run, or pre-programming an integration to inject that context on the fly.
Read article
Why ELNs and LIMS are not enough for PD teams
One of the questions we’re asked frequently is whether Invert is an ELN or LIMS—our answer is that Invert captures both systems’ strengths and fixes their weaknesses. We’ll discuss the trade-offs and shortcomings of ELN and LIMS when it comes to bioprocess data to explain how.
Read article.png&w=3840&q=75)
How Invert uses meta-learning to leverage old bioprocess data
With meta-learning techniques, Invert’s ML team was able to reduce new data needs by as much as 90% by leveraging old data from different, but loosely related, bioprocess programs.
Read article.png&w=3840&q=75)
Pioneers in Bioprocessing: Q&A with Biopharma Executive, Steven Lang, Ph.D.
Biotech and synthetic biology companies have much to do. Handling everything in-house—from strain design to process development—can stretch funding and resources thin.
Read article
A Guide to Build vs Buy: Biotech Software Edition
For biotech and synthetic biology companies, there’s always A LOT of work to do. As these companies quickly learn, trying to handle everything in-house–from strain design and high-throughput screening to process development and beyond–can spread funding and resources thinly.
Read article
Bioprocess Tech Transfer: Navigating The Data Dilemma
The transfer of institutional data and knowledge is critical to the development of biotechnologies, bioproducts, and biotherapeutics.
Read article.png&w=3840&q=75)
From Data Lakes to AI: An Interview with Invert’s Head of AI
Suhas Guruprasad, the Head of AI at Invert, dives into the evolution of artificial intelligence, distinguishing between the actual capabilities of AI and the often exaggerated hype surrounding it.
Read article
Pioneers in Bioprocessing: Q&A with Alexi Goranov of SCiFi Foods
Exciting news! Invert is launching a Q&A series, Pioneers in Bioprocessing, to chat with experts in bioprocessing and biotechnology to discuss their work, the potential of the bioeconomy at large, and the personal viewpoints of the individuals who make this work possible.
Read article
Why Have Bioprocess Data Solutions Been Overlooked…Until Now?
Given the glaring challenge of managing bioprocess data, the question remains: Why have bioprocess data solutions been historically overlooked?
Read article